Trial intelligence / Profile preview

Succinylated gelatin electrolyte sodium acetate versus succinylated gelatin for intraoperative volume therapy in non-cardiac surgery

ChiCTR2200062999Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Start
Sep 2022
Modality
Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of succinylated gelatin + multiple electrolytes + sodium acetate and gelofusine + sodium chloride in hypovolemia (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Change in base excess from baseline at 15 minutes after end of drug infusion and Change in chloride from baseline at 15 minutes after end of drug infusion. Planned start Sep 2022; status: not yet recruiting.

02

Drugs

succinylated gelatin + multiple electrolytes + sodium acetategelofusine + sodium chloride
03

Conditions

hypovolemia

Beyond the preview

Go deeper on ChiCTR2200062999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call